Neovasc provides Tiara implantation rate By: MarketMinute.com Stock News December 06, 2016 at 16:22 PM EST Neovasc Inc. (Nasdaq: NVCN) reported an 86% successful implantation rate for its Tiara transcatheter mitral valve sending the stock price soaring $1.00 to close at $2.42. Related Stocks: Neovasc Inc